Received May 28, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | IM / LA |
Dizzy; Blood pressure high; felt like vomiting; lack of appetite; felt fatigue; Headache; This non-serious case was reported by a consumer via call center representative and described the occurrence of dizziness in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 21-MAY-2026, the patient received the 1st dose of Shingrix (intramuscular, left arm) .5 ml. On 21-MAY-2026, less than a day after receiving Shingrix, the patient experienced dizziness (Verbatim: Dizzy), blood pressure high (Verbatim: Blood pressure high), nausea (Verbatim: felt like vomiting), appetite absent (Verbatim: lack of appetite), fatigue (Verbatim: felt fatigue) and headache (Verbatim: Headache). The outcome of the dizziness, blood pressure high, nausea, appetite absent, fatigue and headache were not resolved. It was unknown if the reporter considered the dizziness, blood pressure high, nausea, appetite absent, fatigue and headache to be related to Shingrix. Additional Information: GSK Receipt Date: 22-MAY-2026 The batch number was not provided upon follow- up with the reporter.
Test Date: 20260521; Test Name: Blood pressure; Result Unstructured Data: (Test Result:High,Unit:unknown,Normal Low:,Normal High:)